Scientific Title: Prognostication of Canine T-cell Lymphoma
Study Investigator: Dr. Dorothee Bienzle
Purpose of the Clinical Study
One of the most commonly diagnosed cancers in dogs is lymphoma. This cancer affects the lymphatic system and the infection-fighting cells in the body. There are many different types in dogs, with B- and T-cell lymphoma being most common. T-cell lymphoma is rarer and most dogs with T-cell lymphoma are considered to have a poor prognosis. Recently, there has been evidence that some T-cell lymphomas have a better prognosis than previously described, but we don’t fully understand this variability which is crucial for accurate prognoses.
Is Your Pet Eligible?
Dogs with a confirmed diagnosis of T-cell lymphoma and no prior treatment with steroids or any type of chemotherapy.
Visits / Samples Required
A fine needle aspirate of the enlarged lymph node for specialized analysis is part of standard of care oncology staging. If the disease is confirmed to be T-cell lymphoma, an additional biopsy (‘Tru-cut’) of the lymph node performed under sedation, will be required for microscopic assessment.
Financial Incentives
The costs associated with the Tru-cut biopsy (anesthesia, procedure and tissue analysis) will be covered. In the event your dog needs to be hospitalized following the biopsy, this will also be covered.
Funding is generously provided by OVC Pet Trust.
